retatrutide trial sign up ๐จThe first phase 3 trial, TRIUMPH-4, top-line data announced today ๐จ ๐ Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis ๐ 28.7% weight loss at 68 A Study of Retatrutide (LY3437943)
Pay in 4 interest-free payments of $6.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 24 - Oct 29
























![Command Beacon (Galaxy Foil) [Secret Lair Drop Series] FLx2](https://cdn.shopify.com/s/files/1/0555/1020/4467/files/de2ab6c3-d4c5-5893-bcda-2b095d4ebc49.jpg?v=1757111560)

